Viridian Therapeutics, Inc. (VRDN)
30.25
+0.87
(+2.96%)
USD |
NASDAQ |
Mar 02, 16:00
29.50
-0.75
(-2.48%)
After-Hours: 07:11
Viridian Therapeutics Total Liabilities (Quarterly) : 177.25M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.346M |
| ADMA Biologics, Inc. | 156.03M |
| Avantor, Inc. | 6.230B |
| Immunovant, Inc. | 66.26M |
| Plus Therapeutics, Inc. | 13.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 899.42M |
| Shareholders Equity (Quarterly) | 722.17M |
| Debt to Equity Ratio | 0.0702 |
| Current Ratio | 12.65 |
| Net Debt Paydown Yield | -0.18% |